Clinical Trials Directory

Trials / Completed

CompletedNCT00990275

Alcohol Exposure and Airway Hyperresponsiveness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
Male
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

Alcohol has consequences including increased risk for upper respiratory tract infections, pneumonia, acute respiratory distress syndrome (ARDS), and alcohol-induced asthma. The investigators have established that airways are specifically impacted by alcohol exposure because the airways are heavily exposed to the vapor phase of alcohol during drinking. These preliminary studies demonstrate that brief alcohol administration significantly attenuates airway hyperresponsiveness (AHR) in a mouse model leading to the hypothesis that alcohol exposure modifies airway hyperresponsiveness through a cAMP/NO- dependent mechanism.

Detailed description

Alcohol has well-established consequences in the lung including increased risk for upper respiratory tract infections, pneumonia and acute respiratory distress syndrome (ARDS). There have even been a few reports of alcohol-induced asthma. Data from the investigators' laboratory have established that the airways are specifically impacted by alcohol exposure. Because the airways are heavily exposed to the vapor phase of alcohol during drinking and airway motor tone is modulated by cAMP, the investigators speculated that airway bronchial motor function would be altered in mice fed alcohol. The investigators' preliminary studies demonstrate that brief alcohol administration significantly attenuates airway hyperresponsiveness (AHR) in a mouse model. This novel finding has led us to hypothesize that: Alcohol exposure modifies airway hyperresponsiveness through a cAMP/NO- dependent mechanism.

Conditions

Interventions

TypeNameDescription
OTHERethanolsubjects will ingest 3 ounces of vodka mixed with fruit juice within 30 min.

Timeline

Start date
2009-10-01
Primary completion
2013-01-16
Completion
2013-01-16
First posted
2009-10-06
Last updated
2023-09-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00990275. Inclusion in this directory is not an endorsement.